Virtual Neurology Analyst & Investor Event highlights key data presented at the 2024 Muscular Dystrophy Association (MDA) and the Alzheimer’s & Parkinson’s Diseases (AD/PD) conferences in a webinar to be held on March 11 at 10 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on RHHBY:
- Roche, Alnylam report KARDIA-2 study met primary endpoint
- Roche and Alnylam report positive topline results from the Phase II KARDIA-2 study in people with hypertension, demonstrating clinically significant blood pressure reductions with zilebesiran when added to standard of care
- Roche downgraded to Hold from Buy at Argus
- Biotech Alert: Searches spiking for these stocks today
- Codexis, Roche in licensing deal for newly engineered double-sranded DNA Ligase
